Harri Juusela

1.9k total citations
34 papers, 1.4k citations indexed

About

Harri Juusela is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Harri Juusela has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 7 papers in Oncology. Recurrent topics in Harri Juusela's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Harri Juusela is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Harri Juusela collaborates with scholars based in Finland. Harri Juusela's co-authors include Teuvo L.J. Tammela, Erkki Rintala, Anssi Auvinen, Ulf‐Håkan Stenman, Liisa Määttänen, S. Rannikko, Matti Hakama, Mirja Ruutu, Pertti Rajala and Jussi Aro and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Harri Juusela

34 papers receiving 1.3k citations

Peers

Harri Juusela

PRM

SURGE

ONCOL

Ken Grigor United Kingdom

John J. Bauer United States

Alex Smith United States

Stefan Zastrow Germany

Takahiro Osawa Japan

Christian Eichelberg Germany

Riichiroh Maruyama Japan

Eric N.P. Subong United States

Daniel Sudilovsky United States

William J. Catalona United States

Ken Grigor United Kingdom

Harri Juusela

675 ×0.8

PRM

489 ×1.0

SURGE

276 ×0.7

ONCOL

401 ×1.2

169 ×0.7

Citations per year, relative to Harri Juusela Harri Juusela (= 1×) peers Ken Grigor

Countries citing papers authored by Harri Juusela

Since Specialization

Citations

This map shows the geographic impact of Harri Juusela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Juusela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Juusela more than expected).

Fields of papers citing papers by Harri Juusela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Juusela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Juusela. The network helps show where Harri Juusela may publish in the future.

Co-authorship network of co-authors of Harri Juusela

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Juusela. A scholar is included among the top collaborators of Harri Juusela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Juusela. Harri Juusela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Juusela, Harri, Teuvo L.J. Tammela, Mirja Ruutu, et al.. (2011). Prostate Cancer Screening: A Survey of Attitudes and Practices among Finnish Physicians in 1999 and 2007. Journal of Medical Screening. 18(1). 46–49. 6 indexed citations

Ruutu, Mirja, Liisa Määttänen, Ulf‐Håkan Stenman, et al.. (2010). Why do men opt out of prostate‐cancer screening? Attitudes and perception among participants and non‐participants of a screening trial. British Journal of Urology. 106(4). 472–477. 8 indexed citations

Määttänen, Liisa, Matti Hakama, Teuvo L.J. Tammela, et al.. (2007). Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. British Journal of Cancer. 96(1). 56–60. 16 indexed citations

Finne, Patrik, Anssi Auvinen, Liisa Määttänen, et al.. (2007). Diagnostic Value of Free Prostate-Specific Antigen among Men with a Prostate-Specific Antigen Level of <3.0μg per Liter. European Urology. 54(2). 362–370. 34 indexed citations

Auvinen, Anssi, Liisa Määttänen, Patrik Finne, et al.. (2004). Test sensitivity of prostate‐specific antigen in the Finnish randomised prostate cancer screening trial. International Journal of Cancer. 111(6). 940–943. 13 indexed citations

Finne, Patrik, Ulf‐Håkan Stenman, Liisa Määttänen, et al.. (2003). The Finnish trial of prostate cancer screening: where are we now?. British Journal of Urology. 92(s2). 22–26. 33 indexed citations

Kaasinen, Eero, Erkki Rintala, Per M. Hellström, et al.. (2002). Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma. European Urology. 42(2). 167–174. 107 indexed citations

Auvinen, Anssi, Liisa Määttänen, Ulf‐Håkan Stenman, et al.. (2002). Lead-time in prostate cancer screening (Finland). Cancer Causes & Control. 13(3). 279–285. 50 indexed citations

Finne, Patrik, Anssi Auvinen, Jussi Aro, et al.. (2002). Estimation of Prostate Cancer Risk on the Basis of Total and Free Prostate-Specific Antigen, Prostate Volume and Digital Rectal Examination. European Urology. 41(6). 619–627. 37 indexed citations

10.

Raitanen, Mika, Risto Aine, Erkki Rintala, et al.. (2002). Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis. European Urology. 41(3). 284–289. 169 indexed citations

11.

Hakama, M, Jussi Aro, Anssi Auvinen, et al.. (2001). Randomized Screening Trial for Prostate Cancer in Finland. European Urology. 39(Suppl. 4). 32–32. 5 indexed citations

12.

Määttänen, Liisa, Anssi Auvinen, Ulf‐Håkan Stenman, et al.. (2001). Three-Year Results of the Finnish Prostate Cancer Screening Trial. JNCI Journal of the National Cancer Institute. 93(7). 552–553. 36 indexed citations

13.

Finne, Patrik, Anssi Auvinen, Harri Juusela, et al.. (2000). Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology. 56(3). 418–422. 122 indexed citations

14.

Määttänen, Liisa, Anssi Auvinen, Ulf‐Håkan Stenman, et al.. (1999). European randomized study of prostate cancer screening: first-year results of the Finnish trial. British Journal of Cancer. 79(7-8). 1210–1214. 67 indexed citations

15.

Juusela, Harri, et al.. (1992). Can Fine Needle Aspiration Biopsy Detect Incidental Prostatic Carcinoma (T1 ) prior to TUR?. European Urology. 21(2). 131–133. 4 indexed citations

16.

Rintala, Esa, K. Jauhiainen, O Alfthan, et al.. (1991). Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy(Bacillus Calmette-Guérin) in Superficial Bladder Cancer. European Urology. 20(1). 19–25. 55 indexed citations

17.

Ruutu, Mirja, et al.. (1991). Efficacy and Side-Effects of Prazosin as a Symptomatic Treatment of Benign Prostatic Obstruction. Scandinavian Journal of Urology and Nephrology. 25(1). 15–19. 8 indexed citations

18.

Laitinen, Liisa, et al.. (1990). Binding of the blood group‐reactive lectins to human adult kidney specimens. The Anatomical Record. 226(1). 10–17. 23 indexed citations

19.

Juusela, Harri. (1978). Renal adenocarcinoma clinical features and factors correlating to survival in 173 patients. A clinical investigation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 193. 3–43. 7 indexed citations

20.

Lehtonen, Timo & Harri Juusela. (1973). Experiences of Vasectomy for Voluntary Sterilisation of Males. Scandinavian Journal of Urology and Nephrology. 7(2-3). 123–126. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact